A Study Evaluating Duloxetine in Patients Hospitalized for Severe Depression

NCT00422162 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

339

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: Duloxetine hydrochloride
DRUG: Placebo

Sponsor

Eli Lilly and Company

Collaborators

[object Object]